Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects

Update Il y a 4 ans
Reference: NCT01405599

Woman and Man

  • | Country :
  • Slovakia
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Evaluation of the effect of hepatic impairment on the pharmacokinetics of ulimorelin after a single intravenous (IV) dose in order to identify potential patients at risks in terms of severity of hepatic dysfunction and to determine whether their dosage should be adjusted.


Inclusion criteria

  • Digestive System Disorders

Links